Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Regulatory T Cells Enhance the Allogeneic Activity of Endothelial-Specific Cytotoxic T Lymphocytes – Protective Effect of Defibrotide

Guenther Eissner, PhD, Isabel Hartmann, Altug Kesikli, MD, Silvia Haffner, Tanja Sax, Ernst Holler, MD, PhD, Massimo Iacobelli, MD

Blood (2011) 118 (21): 4693.

https://doi.org/10.1182/blood.V118.21.4693.4693

Published: 2011

Journal Articles

Polymorphism in the Promoter Region of the Hemeoxygenase I Gene of the Donor Influences Overall Survival and Graft Versus Host Disease.

Armin Gerbitz, MD, Patrick Hillemanns, Christoph Schmid, MD, Andrea Wilke, Rajshri Jayaraman, PhD, Hans-Jochem Kolb, MD, PhD, Heike Bremm, Guenther Eissner, PhD, Ernst Holler, MD, PhD

Blood (2006) 108 (11): 2879.

https://doi.org/10.1182/blood.V108.11.2879.2879

Published: 2006

Journal Articles

Defibrotide, an Endothelium Protecting and Stabilizing Drug, Has Anti-Angiogenic Potential In Vitro and In Vivo.

Guenther Eissner, PhD, Edward K. Geissler, PhD, Massimo Iacobelli, MD, Reinhard Andreesen, MD, Ernst Holler, MD, Gudrun E. Koehl, PhD

Blood (2005) 106 (11): 3956.

https://doi.org/10.1182/blood.V106.11.3956.3956

Published: 2005

Journal Articles

NOD2/CARD15 Mutations Associate with Transplant Related Mortality and GvHD in HLA-Identical Sibling Transplants: Detailed Analysis of Single SNPs in 211 Recipient/Donor Pairs.

Ernst Holler, MD, PhD, Gerhard Rogler, MD, PhD, Joachim Hahn, MD, Hans Herfarth, MD, PhD, Julia Brenmoehl, Guenther Eissner, PhD, Anne M. Dickinson, PhD, Graham Jackson, MD, Hildegard Greinix, MD, PhD, Gerhard Fischer, MD, PhD, Daniel Wolff, MD, Beate Steiner, MD, Joerg Marienhagen, MD, PhD, Reinhard Andreesen, MD.PhD

Blood (2004) 104 (11): 424.

https://doi.org/10.1182/blood.V104.11.424.424

Published: 2004

Journal Articles

Oligotide, a Defibrotide Derivative, Protects Human Microvascular Endothelial Cells Against Fludarabine-Induced Activation, Damage and Allogenicity.

Guenther Eissner, PhD, Massimo Iacobelli, MD, Susanna Blueml, Reinhard Andreesen, MD, PhD, Ernst Holler, MD, PhD

Blood (2004) 104 (11): 4942.

https://doi.org/10.1182/blood.V104.11.4942.4942

Published: 2004

NARROW

Regulatory T Cells Enhance the Allogeneic Activity of Endothelial-Specific Cytotoxic T Lymphocytes – Protective Effect of Defibrotide

Polymorphism in the Promoter Region of the Hemeoxygenase I Gene of the Donor Influences Overall Survival and Graft Versus Host Disease.

Defibrotide, an Endothelium Protecting and Stabilizing Drug, Has Anti-Angiogenic Potential In Vitro and In Vivo.

NOD2/CARD15 Mutations Associate with Transplant Related Mortality and GvHD in HLA-Identical Sibling Transplants: Detailed Analysis of Single SNPs in 211 Recipient/Donor Pairs.

Oligotide, a Defibrotide Derivative, Protects Human Microvascular Endothelial Cells Against Fludarabine-Induced Activation, Damage and Allogenicity.

Email alerts

ASH Publications

American Society of Hematology

Regulatory T Cells Enhance the Allogeneic Activity of Endothelial-Specific Cytotoxic T Lymphocytes – Protective Effect of Defibrotide

Polymorphism in the Promoter Region of the Hemeoxygenase I Gene of the Donor Influences Overall Survival and Graft Versus Host Disease.

Defibrotide, an Endothelium Protecting and Stabilizing Drug, Has Anti-Angiogenic Potential In Vitro and In Vivo.

NOD2/CARD15 Mutations Associate with Transplant Related Mortality and GvHD in HLA-Identical Sibling Transplants: Detailed Analysis of Single SNPs in 211 Recipient/Donor Pairs.

Oligotide, a Defibrotide Derivative, Protects Human Microvascular Endothelial Cells Against Fludarabine-Induced Activation, Damage and Allogenicity.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only